Cognitive effects of risperidone in children with autism and irritable behavior (Q34112075)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Cognitive effects of risperidone in children with autism and irritable behavior	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Cognitive effects of risperidone in children with autism and irritable behavior (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lawrence Scahill

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Christopher J McDougle

3

object named as

Christopher J McDougle

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

L Eugene Arnold

7

object named as

L Eugene Arnold

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Naomi B. Swiezy

12

object named as

Naomi Swiezy

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Benedetto Vitiello

8

object named as

Benedetto Vitiello

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

object named as

Michael G Aman

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

object named as

Elaine Tierney

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

object named as

Pegeen Cronin

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jill A. Hollway

2

object named as

Jill A Hollway

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kathleen Koenig

14

object named as

Kathleen Koenig

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jaswinder K Ghuman

15

object named as

Jaswinder K Ghuman

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Allison Gavaletz

10

object named as

Allison Gavaletz

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Courtney Wheeler

13

object named as

Courtney Wheeler

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

16

object named as

David J Posey

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

James T McCracken

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Louise Ritz

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Child and Adolescent Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

227-236

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Acute and long-term safety and tolerability of risperidone in children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

On the trail of a cognitive enhancer for the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Risperidone in children with autism and serious behavioral problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Cognitive improvement in schizophrenia with novel antipsychotic medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

5 July 2018

The Purdue pegboard; norms and studies of reliability and validity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

Risperidone and cognitive function in children with disruptive behavior disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

Adverse effects of risperidone on spatial working memory in first-episode schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

The effects of clozapine and risperidone on spatial working memory in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935828

28 October 2018

The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18582177

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1089/CAP.2007.0133

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34112075&oldid=2055117023"